Wolf A - Search Results

1

Impact of Sub-Retinal Fluid on the Long-Term Incidence of Macular Atrophy in Neovascular Age-related Macular Degeneration under Treat & Extend Anti-Vascular Endothelial Growth Factor Inhibitors.

Siedlecki J, Fischer C, Schworm B, Kreutzer TC, Luft N, Kortuem KU, Schumann RG, Wolf A, Priglinger SG. Siedlecki J, et al. Among authors: wolf a. Sci Rep. 2020 May 15;10(1):8036. doi: 10.1038/s41598-020-64901-9. Sci Rep. 2020. PMID: 32415240 Free PMC article.

2

Optical coherence tomography for the detection of laser in situ keratomileusis in donor corneas.

Priglinger SG, Neubauer AS, May CA, Alge CS, Wolf AH, Mueller A, Ludwig K, Kampik A, Welge-Luessen U. Priglinger SG, et al. Among authors: wolf ah. Cornea. 2003 Jan;22(1):46-50. doi: 10.1097/00003226-200301000-00011. Cornea. 2003. PMID: 12502948

3

Detection of laser in situ keratomileusis in a postmortem eye using optical coherence tomography.

Wolf AH, Neubauer AS, Priglinger SG, Kampik A, Welge-Luessen UC. Wolf AH, et al. J Cataract Refract Surg. 2004 Feb;30(2):491-5. doi: 10.1016/j.jcrs.2003.06.007. J Cataract Refract Surg. 2004. PMID: 15030847

4

Absence of scar formation in human donor cornea with prior laser in situ keratomileusis.

Priglinger SG, May CA, Alge CS, Wolf A, Neubauer AS, Kampik A, Welge-Luessen U. Priglinger SG, et al. Among authors: wolf a. J Cataract Refract Surg. 2005 Jul;31(7):1403-8. doi: 10.1016/j.jcrs.2004.12.054. J Cataract Refract Surg. 2005. PMID: 16105614

5

Immunohistochemical findings after LASIK confirm in vitro LASIK model.

Priglinger SG, May CA, Alge CS, Wolf A, Neubauer AS, Haritoglou C, Kampik A, Welge-Lussen U. Priglinger SG, et al. Among authors: wolf a. Cornea. 2006 Apr;25(3):331-5. doi: 10.1097/01.ico.0000183535.99651.7b. Cornea. 2006. PMID: 16633035

6

Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema.

Haritoglou C, Kook D, Neubauer A, Wolf A, Priglinger S, Strauss R, Gandorfer A, Ulbig M, Kampik A. Haritoglou C, et al. Among authors: wolf a. Retina. 2006 Nov-Dec;26(9):999-1005. doi: 10.1097/01.iae.0000247165.38655.bf. Retina. 2006. PMID: 17151486 Clinical Trial.

7

Intravitreal bevacizumab injections for treatment of central retinal vein occlusion: six-month results of a prospective trial.

Priglinger SG, Wolf AH, Kreutzer TC, Kook D, Hofer A, Strauss RW, Alge CS, Kunze C, Haritoglou C, Kampik A. Priglinger SG, et al. Among authors: wolf ah. Retina. 2007 Oct;27(8):1004-12. doi: 10.1097/IAE.0b013e3180ed458d. Retina. 2007. PMID: 18040236 Clinical Trial.

8

The protective effect of quercetin against oxidative stress in the human RPE in vitro.

Kook D, Wolf AH, Yu AL, Neubauer AS, Priglinger SG, Kampik A, Welge-Lüssen UC. Kook D, et al. Among authors: wolf ah. Invest Ophthalmol Vis Sci. 2008 Apr;49(4):1712-20. doi: 10.1167/iovs.07-0477. Invest Ophthalmol Vis Sci. 2008. PMID: 18385095

9

Optimizing the deswelling process of organ-cultured corneas.

Wolf AH, Welge-Lüssen UC, Priglinger S, Kook D, Grueterich M, Hartmann K, Kampik A, Neubauer AS. Wolf AH, et al. Cornea. 2009 Jun;28(5):524-9. doi: 10.1097/ICO.0b013e3181901dde. Cornea. 2009. PMID: 19421045

10

Oxidative stress-mediated induction of MMP-1 and MMP-3 in human RPE cells.

Alge-Priglinger CS, Kreutzer T, Obholzer K, Wolf A, Mempel M, Kernt M, Kampik A, Priglinger SG. Alge-Priglinger CS, et al. Among authors: wolf a. Invest Ophthalmol Vis Sci. 2009 Nov;50(11):5495-503. doi: 10.1167/iovs.08-3193. Epub 2009 Jun 10. Invest Ophthalmol Vis Sci. 2009. PMID: 19516002

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,364 results

Search Page

Filters